GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » Accounts Payable

Noile-Immune Biotech (TSE:4893) Accounts Payable : 円46.9 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech Accounts Payable?

Noile-Immune Biotech's Accounts Payable for the quarter that ended in Mar. 2024 was 円46.9 Mil.

Noile-Immune Biotech's quarterly Accounts Payable declined from Sep. 2023 (円115.4 Mil) to Dec. 2023 (円18.7 Mil) but then increased from Dec. 2023 (円18.7 Mil) to Mar. 2024 (円46.9 Mil).

Noile-Immune Biotech's annual Accounts Payable increased from Dec. 2021 (円30.6 Mil) to Dec. 2022 (円217.8 Mil) but then declined from Dec. 2022 (円217.8 Mil) to Dec. 2023 (円18.7 Mil).


Noile-Immune Biotech Accounts Payable Historical Data

The historical data trend for Noile-Immune Biotech's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech Accounts Payable Chart

Noile-Immune Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Accounts Payable
3.70 30.61 217.82 18.72

Noile-Immune Biotech Quarterly Data
Dec20 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable Get a 7-Day Free Trial Premium Member Only - 69.43 115.42 18.72 46.87

Noile-Immune Biotech Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Noile-Immune Biotech Accounts Payable Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Noile-Immune Biotech (TSE:4893) Business Description

Traded in Other Exchanges
N/A
Address
2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012
Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines